Al-Hassan Leena, Elbadawi Hana, Osman Einas, Ali Sara, Elhag Kamal, Cantillon Daire, Wille Julia, Seifert Harald, Higgins Paul G
Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, United Kingdom.
Department of Microbiology, Soba University Hospital, University of Khartoum, Khartoum, Sudan.
Front Microbiol. 2021 Feb 26;12:628736. doi: 10.3389/fmicb.2021.628736. eCollection 2021.
Carbapenem resistant (CRAb) is an important global pathogen contributing to increased morbidity and mortality in hospitalized patients, due to limited alternative treatment options. Nine international clonal (IC) lineages have been identified in many countries worldwide, however, data still lacks from some parts of the world, particularly in Africa. We hereby present the molecular epidemiology of MDR from four hospitals in Khartoum, Sudan, collected from 2017 to 2018. Forty-two isolates were whole-genome sequenced, and subsequent molecular epidemiology was determined by core genome MLST (cgMLST), and their resistomes identified. All isolates had an array of diverse antibiotic resistance mechanisms conferring resistance to multiple classes of antibiotics. We found a predominance (88%) of IC2 (with the intrinsic OXA-66 and acquired OXA-23), and some with NDM-1. IC2 isolates were sub-divided into 4 STs separated by 5 to 431 allelic differences, and with evidence of seven transmission clusters. Isolates belonging to IC1, IC5, and IC9 were also identified. These data illustrate that MDR IC2 are widely distributed in Khartoum hospitals and are in possession of multiple antibiotic resistance determinants.
耐碳青霉烯类鲍曼不动杆菌(CRAb)是一种重要的全球病原体,由于可选择的治疗方案有限,导致住院患者的发病率和死亡率增加。在世界许多国家已鉴定出9种国际克隆(IC)谱系,然而,世界上一些地区,特别是非洲,仍然缺乏相关数据。在此,我们展示了2017年至2018年从苏丹喀土穆的四家医院收集的耐多药菌的分子流行病学情况。对42株分离株进行了全基因组测序,随后通过核心基因组多位点序列分型(cgMLST)确定其分子流行病学特征,并鉴定其耐药基因组。所有分离株都具有一系列不同的抗生素耐药机制,对多种类别的抗生素具有耐药性。我们发现IC2占主导地位(88%)(具有内在的OXA-66和获得性的OXA-23),还有一些带有NDM-1。IC2分离株被细分为4个序列型,等位基因差异为5至431个,并有7个传播簇的证据。还鉴定出了属于IC1、IC5和IC9的分离株。这些数据表明,耐多药的IC2在喀土穆的医院中广泛分布,并拥有多种抗生素耐药决定因素。